Analogic taps Miller as CEO

Article

A new leader has been named at Analogic. Company founder, board chairman, and CEO Bernard M. Gordon announced Jan. 25 that Thomas J. Miller Jr., will assume the role of CEO effective Feb 1. Gordon will remain as board chairman.Gordon, who founded

A new leader has been named at Analogic. Company founder, board chairman, and CEO Bernard M. Gordon announced Jan. 25 that Thomas J. Miller Jr., will assume the role of CEO effective Feb 1. Gordon will remain as board chairman.

Gordon, who founded Analogic in 1969, is an R&D icon, having developed numerous technologies, notably the first high-speed analog-to-digital converter. He was awarded the National Medal of Technology in 1986. Miller has served as president and COO of Analogic for the past 15 months. During this time he developed and began implementing a five-year strategic plan. Prior to joining Analogic, Miller had been president and CEO of Carl Zeiss, Inc., world general manager of Carl Zeiss Medical Group, and group vice president of imaging systems for Siemens Medical Systems' North American operations.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.